Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial

被引：1
|
作者：
Andreassen, A. K. [1 ]
Andersson, B. [2 ]
Gustafsson, F. [3 ]
Eiskjaer, H. [4 ]
Radegran, G. [5 ,6 ]
Gude, E. [1 ]
Jansson, K. [7 ,8 ]
Solbu, D. [9 ]
Karason, K. [2 ]
Arora, S. [1 ]
Dellgren, G. [10 ]
Gullestad, I. [1 ]
机构：
[1] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[3] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark
[5] Skane Univ Hosp, Dept Cardiol, Clin Heart Failure & Valvular Dis, Lund, Sweden
[6] Lund Univ, Lund, Sweden
[7] Cty Council Ostergotland, Dept Cardiol, Heart & Med Ctr, Linkoping, Sweden
[8] Linkoping Univ, Linkoping, Sweden
[9] Novartis Norge AS, Oslo, Norway
[10] Sahlgrens Univ Hosp, Transplant Inst, Gothenburg, Sweden
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2015年 / 34卷 / 04期
关键词：
D O I：
10.1016/j.healun.2015.01.346
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
332
引用
收藏
页码：S129 / S130
页数：2
相关论文
共 50 条
  • [41] 15-Year Follow-up of a Multicenter, Randomized, Calcineurin Inhibitor Withdrawal Study in Kidney Transplantation
    Roodnat, Joke I.
    Hilbrands, Luuk B.
    Hene, Ronald J.
    de Sevaux, Ruud G. L.
    Gregoor, Peter J. H. Smak
    Kal-van Gestel, Judith A.
    Konijn, Cynthia
    van Zuilen, Arjan
    van Gelder, Teun
    Hoitsma, Andries J.
    Weimar, Willem
    [J]. TRANSPLANTATION, 2014, 98 (01) : 47 - 53
  • [42] Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial
    Cillo, Umberto
    Saracino, Laura
    Vitale, Alessandro
    Bertacco, Alessandra
    Salizzoni, Mauro
    Lupo, Francesco
    Colledan, Michele
    Corno, Vittorio
    Rossi, Giorgio
    Reggiani, Paolo
    Baccarani, Umberto
    Bresadola, Vittorio
    De Carlis, Luciano
    Mangoni, Iacopo
    Morales, Raphael Ramirez
    Agnes, Salvatore
    Nure, Erida
    [J]. LIVER TRANSPLANTATION, 2019, 25 (02) : 242 - 251
  • [43] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [44] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART.
    Potena, L.
    Barberini, F.
    Boffini, M.
    Maiello, C.
    Pedrazzini, G.
    Faggian, G.
    Gerosa, G.
    Lilla, P.
    Marraudino, N.
    Corda, M.
    Bernazzali, S.
    Guarisco, R.
    Livi, U.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 93 - 93
  • [45] Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
    Gullestad, Lars
    Eiskjaer, Hans
    Gustafsson, Finn
    Riise, Gerdt C.
    Karason, Kristjan
    Dellgren, Goran
    Radegran, Goran
    Hansson, Lennart
    Gude, Einar
    Bjortuft, Oystein
    Jansson, Kjell
    Schultz, Hans Henrik
    Solbu, Dag
    Iversen, Martin
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 (07) : 819 - 829
  • [46] OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 5 YEAR DATA OF THE APOLLO TRIAL
    Rath, T.
    Sommerer, C.
    Suwelack, B.
    Arns, W.
    Haller, H.
    Reinke, P.
    Budde, K.
    Baeumer, D.
    Porstner, M.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 50 - 50
  • [47] Long Term Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial
    Gullestad, L.
    Eiskjaer, H.
    Gustafsson, F.
    Riise, G.
    Karason, K.
    Dellgren, G.
    Radegran, G.
    Hansson, L.
    Gude, E.
    Bjortuft, O.
    Jansson, K.
    Solbu, D.
    Iversen, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S85 - S85
  • [48] Outcome on Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 4 Year Data of the APOLLO Trial
    Budde, K.
    Sommerer, C.
    Reinke, P.
    Haller, H.
    Arns, W.
    Witzke, O.
    Suwelack, B.
    May, C.
    Baeumer, D.
    Paulus, E.
    Rath, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 312
  • [49] 4 YEAR DATA OF THE APOLLO TRIAL: OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Sommerer, C.
    Rath, T.
    Haller, H.
    Arns, W.
    Suwelack, B.
    Reinke, P.
    May, C.
    Baeumer, D.
    Paulus, E. -M.
    Witzke, O.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
  • [50] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M.
    Witzke, O.
    Reinke, P.
    Rath, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 298 - 298
12345